Roel P.L.M. Hoogma

2.7k total citations · 1 hit paper
29 papers, 1.6k citations indexed

About

Roel P.L.M. Hoogma is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Roel P.L.M. Hoogma has authored 29 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Genetics and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Roel P.L.M. Hoogma's work include Diabetes Management and Research (17 papers), Diabetes Treatment and Management (9 papers) and Diabetes and associated disorders (8 papers). Roel P.L.M. Hoogma is often cited by papers focused on Diabetes Management and Research (17 papers), Diabetes Treatment and Management (9 papers) and Diabetes and associated disorders (8 papers). Roel P.L.M. Hoogma collaborates with scholars based in Netherlands, Germany and Italy. Roel P.L.M. Hoogma's co-authors include E. Hommel, Birthe Susanne Olsen, N. Sulli, Ulrike Schierloh, Tadej Battelino, Ignacio Conget, Jan Bolinder, Ingrid Schütz-Fuhrmann, T. H. M. Falke and Esther Donga and has published in prestigious journals such as Diabetes Care, Diabetes and British Journal of Cancer.

In The Last Decade

Roel P.L.M. Hoogma

29 papers receiving 1.5k citations

Hit Papers

The use and efficacy of continuous glucose monitoring in ... 2012 2026 2016 2021 2012 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roel P.L.M. Hoogma Netherlands 18 1.2k 815 524 127 111 29 1.6k
Per‐Eric Lins Sweden 21 874 0.7× 405 0.5× 237 0.5× 101 0.8× 98 0.9× 45 1.3k
Eero Lindholm Sweden 21 480 0.4× 355 0.4× 479 0.9× 115 0.9× 28 0.3× 27 1.4k
Ji‐Oh Mok South Korea 25 708 0.6× 437 0.5× 150 0.3× 326 2.6× 68 0.6× 92 1.6k
R Pelkonen Finland 23 791 0.7× 312 0.4× 187 0.4× 162 1.3× 45 0.4× 59 1.3k
Marianne Klose Denmark 23 1.1k 0.9× 172 0.2× 76 0.1× 254 2.0× 329 3.0× 89 1.6k
Bertil Ekman Sweden 22 1.3k 1.1× 243 0.3× 130 0.2× 90 0.7× 41 0.4× 75 1.6k
Thomas Guttuso United States 17 572 0.5× 119 0.1× 425 0.8× 19 0.1× 141 1.3× 35 1.2k
Pierre Zelissen Netherlands 28 1.6k 1.3× 540 0.7× 127 0.2× 249 2.0× 104 0.9× 72 2.3k
Jan Calissendorff Sweden 27 1.1k 0.9× 448 0.5× 94 0.2× 239 1.9× 138 1.2× 85 2.0k
C.–D. Agardh Sweden 23 562 0.5× 259 0.3× 248 0.5× 191 1.5× 107 1.0× 42 1.6k

Countries citing papers authored by Roel P.L.M. Hoogma

Since Specialization
Citations

This map shows the geographic impact of Roel P.L.M. Hoogma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roel P.L.M. Hoogma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roel P.L.M. Hoogma more than expected).

Fields of papers citing papers by Roel P.L.M. Hoogma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roel P.L.M. Hoogma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roel P.L.M. Hoogma. The network helps show where Roel P.L.M. Hoogma may publish in the future.

Co-authorship network of co-authors of Roel P.L.M. Hoogma

This figure shows the co-authorship network connecting the top 25 collaborators of Roel P.L.M. Hoogma. A scholar is included among the top collaborators of Roel P.L.M. Hoogma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roel P.L.M. Hoogma. Roel P.L.M. Hoogma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hommel, E., Birthe Susanne Olsen, Tadej Battelino, et al.. (2014). Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study. Acta Diabetologica. 51(5). 845–851. 84 indexed citations
2.
Yarde, F., Yvonne T. van der Schouw, Harold W. de Valk, et al.. (2014). Age at menopause in women with type 1 diabetes mellitus: the OVADIA study. Human Reproduction. 30(2). 441–6. 31 indexed citations
3.
IJzerman, Richard G., Marc C. Huisman, Roel P.L.M. Hoogma, et al.. (2013). Cerebral Blood Flow and Glucose Metabolism in Appetite-Related Brain Regions in Type 1 Diabetic Patients After Treatment With Insulin Detemir and NPH Insulin. Diabetes Care. 36(12). 4050–4056. 12 indexed citations
4.
Verschoor, Arie J., et al.. (2012). Vesiculopustular dermatosis: An uncommon side-effect of liraglutide?. Journal of Diabetes and its Complications. 26(5). 458–459. 16 indexed citations
5.
Battelino, Tadej, Ignacio Conget, Birthe Susanne Olsen, et al.. (2012). The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 55(12). 3155–3162. 365 indexed citations breakdown →
6.
Donga, Esther, Marieke van Dijk, J. Gert van Dijk, et al.. (2010). Partial Sleep Restriction Decreases Insulin Sensitivity in Type 1 Diabetes. Diabetes Care. 33(7). 1573–1577. 126 indexed citations
7.
Liebl, Andreas, Roel P.L.M. Hoogma, Éric Renard, et al.. (2009). A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion. Diabetes Obesity and Metabolism. 11(11). 1001–1008. 53 indexed citations
8.
Hoogma, Roel P.L.M., et al.. (2006). Safety of Insulin Glulisine when Given by Continuous Subcutaneous Infusion Using an External Pump in Patients with Type 1 Diabetes. Hormone and Metabolic Research. 38(6). 429–433. 49 indexed citations
9.
Bots, Michiel L., Henk J.G. Bilo, Roel P.L.M. Hoogma, et al.. (2006). Determinants of daily insulin use in Type 1 diabetes. Journal of Diabetes and its Complications. 20(6). 356–360. 15 indexed citations
10.
Brands, Augustina M.A., Roy P. C. Kessels, Roel P.L.M. Hoogma, et al.. (2006). Cognitive Performance, Psychological Well-Being, and Brain Magnetic Resonance Imaging in Older Patients With Type 1 Diabetes. Diabetes. 55(6). 1800–1806. 117 indexed citations
11.
Bots, Michiel L., Henk J.G. Bilo, Roel P.L.M. Hoogma, et al.. (2005). High cumulative insulin exposure: a risk factor of atherosclerosis in type 1 diabetes?. Atherosclerosis. 181(1). 185–192. 23 indexed citations
14.
Jacobs, Michael J., et al.. (1997). Effect of BMI, insulin dose and number of injections on glycaemic control in insulin-using diabetic patients. The Netherlands Journal of Medicine. 50(4). 153–159. 9 indexed citations
15.
Kruseman, A. C. Nieuwenhuijzen, et al.. (1995). The effect of GHRH on TSH release in rats in vivo and in vitro. Journal of Endocrinological Investigation. 18(3). 214–219. 1 indexed citations
16.
Kwekkeboom, D. J., et al.. (1993). Octreotide scintigraphy for the detection of paragangliomas.. PubMed. 34(6). 873–8. 139 indexed citations
17.
Hoogma, Roel P.L.M., et al.. (1992). MRI screening of kindred at risk of developing paragangliomas: support for genomic imprinting in hereditary glomus tumours. British Journal of Cancer. 65(6). 903–907. 35 indexed citations
18.
Falke, T. H. M., et al.. (1991). MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas.. Radiographics. 11(1). 37–57. 94 indexed citations
19.
Hoogma, Roel P.L.M., et al.. (1990). Iodine-123-metaiodobenzylguanidine scintigraphy in patients with chemodectomas of the head and neck region.. PubMed. 31(7). 1147–55. 35 indexed citations
20.
Leeuw, Peter W. de, et al.. (1983). Humoral and Renal Effects of MK-421 (Enalapril) in Hypertensive Subjects. Journal of Cardiovascular Pharmacology. 5(5). 731–736. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026